Author Question: A potential extraneous variable when interviewing convicted prisoners about their remorse for their ... (Read 166 times)

mrsjacobs44

  • Hero Member
  • *****
  • Posts: 500
A potential extraneous variable when interviewing convicted prisoners about their remorse for their crime in order to determine eligibility for parole is the
 
  a) good participant effect
 b) Rosenthal effect.
 c) experimenter effect.
 d) effect of experimenter expectancy.

Question 2

The ___________ is the amount of variability in the dependent variable attributable to each source.
 
  a) sum of square
 b) standard deviation
 c) mean square
 d) correlation coefficient



scrocafella

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

A

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library